Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Cornberg

Showing results (11-20 of 350) with videos related to

Pageof 35
Sort By:
Journal of Experimental Pharmacology|April 23, 2021
Experimental Drugs for the Treatment of Hepatitis DLisa Sandmann, Markus Cornberg
Gut|January 28, 2026
Real-world evidence supports earlier treatment in HBeAg-positive but not HBeAg-negative chronic hepatitis B virus infectionMarkus Cornberg, Pietro Lampertico
Current Opinion in Virology|January 31, 2016
Hepatitis C virus infection from the perspective of heterologous immunityMarkus Cornberg, Heiner Wedemeyer
Current Opinion in Pharmacology|September 2, 2021
Towards eradication of HBV: Treatment approaches and status of clinical trialsLisa Sandmann, Markus Cornberg
Hepatology (Baltimore, Md.)|March 1, 2022
Lonafarnib-A new member of the Delta Force?Christopher A Dietz, Markus Cornberg
Pharmazie in Unserer Zeit|January 4, 2011
[Current Guidelines for treatment of hepatitis B. Correct diagnosis is the prerequisite.]Markus Cornberg, Michael P Manns
Nature Reviews. Gastroenterology & Hepatology|February 1, 2018
Hepatitis: No cure for hepatitis B and D without targeting integrated viral DNA?Markus Cornberg, Michael P Manns
Epigenomics|April 24, 2026
Combining epigenetic therapy and immunotherapeutic avenues for chronic HBV infectionYin-Han Chou, Markus Cornberg
Nature Medicine|April 2, 2004
Embedding T cells in the matrixLiisa K Selin, Markus Cornberg
Lancet (London, England)|December 4, 2014
New kids on the block--step by step to an ideal HCV therapyMarkus Cornberg, Michael P Manns
Pageof 35

Showing results (11-20 of 350) with videos related to

Sort By:
Pageof 35
Journal of Experimental Pharmacology|April 23, 2021
Experimental Drugs for the Treatment of Hepatitis DLisa Sandmann, Markus Cornberg
Gut|January 28, 2026
Real-world evidence supports earlier treatment in HBeAg-positive but not HBeAg-negative chronic hepatitis B virus infectionMarkus Cornberg, Pietro Lampertico
Current Opinion in Virology|January 31, 2016
Hepatitis C virus infection from the perspective of heterologous immunityMarkus Cornberg, Heiner Wedemeyer
Current Opinion in Pharmacology|September 2, 2021
Towards eradication of HBV: Treatment approaches and status of clinical trialsLisa Sandmann, Markus Cornberg
Hepatology (Baltimore, Md.)|March 1, 2022
Lonafarnib-A new member of the Delta Force?Christopher A Dietz, Markus Cornberg
Pharmazie in Unserer Zeit|January 4, 2011
[Current Guidelines for treatment of hepatitis B. Correct diagnosis is the prerequisite.]Markus Cornberg, Michael P Manns
Nature Reviews. Gastroenterology & Hepatology|February 1, 2018
Hepatitis: No cure for hepatitis B and D without targeting integrated viral DNA?Markus Cornberg, Michael P Manns
Epigenomics|April 24, 2026
Combining epigenetic therapy and immunotherapeutic avenues for chronic HBV infectionYin-Han Chou, Markus Cornberg
Nature Medicine|April 2, 2004
Embedding T cells in the matrixLiisa K Selin, Markus Cornberg
Lancet (London, England)|December 4, 2014
New kids on the block--step by step to an ideal HCV therapyMarkus Cornberg, Michael P Manns
Pageof 35